PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients

Triple-negative breast cancer (TNBC) constitutes a heterogeneous breast cancer subgroup with poor prognosis; survival rates are likely to be lower with TNBC compared to other breast cancer subgroups. For this disease, systemic adjuvant chemotherapy regimens often yield suboptimal clinical results. T...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Oncol
Главные авторы: Absmaier, Magdalena, Napieralski, Rudolf, Schuster, Tibor, Aubele, Michaela, Walch, Axel, Magdolen, Viktor, Dorn, Julia, Gross, Eva, Harbeck, Nadia, Noske, Aurelia, Kiechle, Marion, Schmitt, Manfred
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2018
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5807037/
https://ncbi.nlm.nih.gov/pubmed/29328369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4241
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы